Potential side effects to GLP-1 agonists: Understanding their safety and tolerability
QD, once daily
Jianfeng Liu, [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), Turck, D., Castenmiller, J., de Henauw, S., Hirsch-Ernst, K
Zepbound (tirzepatide) injection product page
For Eli Lilly, Mounjaro has taken off to the races extremely strong since its spring approval this year, surpassing market expectations by more than double